Early research (Phase 1)Study completedNCT01534598What this trial is testingFdCyd and THU for Advanced Solid TumorsWho this might be right forNeoplasms National Cancer Institute (NCI) 59
Large-scale testing (Phase 3)Study completedNCT00008398What this trial is testingSargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck CancerWho this might be right forHead and Neck CancerOral ComplicationsRadiation Toxicity Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Study completedNCT02072863What this trial is testingOprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Amgen 9
Testing effectiveness (Phase 2)UnknownNCT00178763What this trial is testingHyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas CancerWho this might be right forPancreatic Neoplasms The University of Texas Health Science Center, Houston 36
Testing effectiveness (Phase 2)Looking for participantsNCT06567314What this trial is testingPhase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell CarcinomaWho this might be right forCutaneous Squamous Cell Carcinoma M.D. Anderson Cancer Center 24
Not applicableWithdrawnNCT03817216What this trial is testingProstatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate CancerWho this might be right forBenign Prostatic Hyperplasia (BPH)Prostate Cancer Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT03203616What this trial is testingKadcyla In pAtients With bRAin MetastasisWho this might be right forMetastatic HER2-positive Breast Cancer With Brain Metastasis Jules Bordet Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06662006What this trial is testingNal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer PatientsWho this might be right forAdvanced Metastatic Pancreatic Cancer The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Not applicableActive Not RecruitingNCT07393204What this trial is testingItalian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCLWho this might be right forRelapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-Cell Lymphoma Andrés José Maria Ferreri 150
Not applicableEnded earlyNCT00253552What this trial is testingG-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more OHSU Knight Cancer Institute 4
Not applicableStudy completedNCT04416438What this trial is testingCOVID-19 Epidemic and Patients With Myeloproliferative NeoplasiasWho this might be right forMyeloproliferative NeoplasmCOVID-19 Infection French Innovative Leukemia Organisation 1,793
Not applicableStudy completedNCT03265938What this trial is testingEvaluation of Video Laryngoscopy in Patients With Head and Neck PathologyWho this might be right forDifficult Intubation Icahn School of Medicine at Mount Sinai 100
Not applicableUnknownNCT05606848What this trial is testingTo Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal CancerWho this might be right forGastrointestinal Cancer Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd 350
Testing effectiveness (Phase 2)Looking for participantsNCT06791148What this trial is testingLow-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ CancerWho this might be right forGastric Cancer The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 45
Not applicableStudy completedNCT00003648What this trial is testingGenetic Study of Patients and Families With a History of Colorectal CancerWho this might be right forColorectal Cancer Alliance for Clinical Trials in Oncology 1,500
Testing effectiveness (Phase 2)Study completedNCT00244855What this trial is testingRituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin LymphomaWho this might be right forContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Marginal Zone Lymphoma+20 more Fred Hutchinson Cancer Center 32
Early research (Phase 1)Study completedNCT02640755What this trial is testingAbsorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose PhaseWho this might be right forSolid Malignancies AstraZeneca 4
Not applicableStudy completedNCT00042926What this trial is testingDiagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth CancerWho this might be right forHead and Neck Cancer Alliance for Clinical Trials in Oncology 161
Testing effectiveness (Phase 2)Study completedNCT00244985What this trial is testingRituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Roswell Park Cancer Institute 42
Testing effectiveness (Phase 2)Study completedNCT00026143What this trial is testingInterleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant MelanomaWho this might be right forRecurrent MelanomaStage IV Melanoma National Cancer Institute (NCI) 60